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 To simultaneously control infl ammation and facilitate dentin regeneration, a copolymeric 
micelle-in-microsphere platform is developed in this study, aiming to simultaneously release a 
hydrophobic drug to suppress infl ammation and a hydrophilic biomolecule to enhance odon-
togenic differentiation of dental pulp stem cells in a distinctly controlled fashion. A series of 
chitosan- graft -poly(lactic acid) copolymers is synthesized with varying lactic acid and chitosan 
weight ratios, self-assembled into nanoscale micelle-like core–shell structures in an aqueous 
system, and subsequently crosslinked into microspheres through electrostatic interaction with 
sodium tripolyphosphate. A hydrophobic biomolecule either coumarin-6 or fl uocinolone ace-
tonide (FA) is encapsulated into the hydrophobic cores of the micelles, while a hydrophilic bio-
molecule either bovine serum albumin or bone morphogenetic protein 2 (BMP-2) is entrapped 
in the hydrophilic shells and the interspaces among the micelles. Both hydrophobic and hydro-
philic biomolecules are delivered with distinct and tunable release patterns. Delivery of FA 
and BMP-2 simultaneously suppresses infl ammation and 
enhances odontogenesis, resulting in signifi cantly enhanced 
mineralized tissue regeneration. This result also demonstrates 
the potential for this novel delivery system to deliver multiple 
therapeutics and to achieve synergistic effects. 
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 1.  Introduction 
 The regeneration of tissues and organs is typically driven 
by the synergistic effects of various biomolecules acting on 
cells as they grow and mature. [ 1,2 ] Therefore, simultaneous 
or sequential delivery of multiple biomolecules is typically 
needed in order to regenerate damaged, diseased, or pre-
viously removed tissue. [ 3,4 ] Advanced co-delivery vehicles 
with dimensions ranging from micrometers to nanometers 
are being actively investigated. [ 5–8 ] In comparison to single 
biomolecule delivery, co-delivery systems may possibly 
enhance therapeutic effi cacy of tissue regeneration. [ 9,10 ] 
However, biomolecules needed in tissue regeneration often 
have diverse biochemical and physiological properties. [ 11,12 ] 
 For dentin regeneration, drug delivery systems must 
control dental pulp infl ammation and form a reparative 
dentin barrier to seal the pulp from exposure. Excessive 
or prolonged infl ammation can impede tissue forma-
tion and remodeling, leading to tissue necrosis. [ 13 ] When 
lipopolysaccharide (LPS) was used to induce an infl am-
matory dental microenvironment, odontoblastic differen-
tiation and dentin regeneration were inhibited through 
the activation of the inhibitory NF-κB pathway. [ 14 ] It was 
shown that sustained infl ammation compromises bone 
morphogenetic protein (BMP)-induced bone formation. [ 15 ] 
Therefore, in a clinical setting, local delivery of both an 
anti-infl ammatory drug and an odontogenic growth 
factor (such as BMP) is necessary to generate a suitable 
microenvironment to rapidly regenerate dentin tissues to 
seal the defect and protect the pulp tissue. 
 As most fi rst-line anti-infl ammatory drugs are hydro-
phobic and potent odontogenic growth factors are hydro-
philic, it remains a great challenge to co-deliver these two 
types of therapeutics. Fluocinolone acetonide (FA) is a 
steroid drug that has been widely used clinically to relieve 
infl ammation in many infl ammatory diseases including 
mucosal disorders and pulpitis. [ 14,16 ] FA is hydrophobic 
and is only soluble in organic solvents such as dimethyl 
sulfoxide. [ 17 ] On the contrary, BMP-2, an FDA-approved 
drug used to stimulate bone growth, is hydrophilic and 
its direct contact with an organic solvent during the 
encapsulation process compromises its bioactivity. [ 18,19 ] 
As a result, most delivery systems are not optimal for co-
delivery of these two types of therapeutics. 
 For the delivery of single biomolecules, microspheres 
are advantageous because they can deliver a large payload 
and achieve long-term controlled release. [ 20–22 ] Tradition-
ally, single-component microspheres can be optimized for 
delivering one type of biomolecule or multiple biomole-
cules that have similar properties. [ 23–26 ] Without matching 
biochemical properties, it is challenging to effectively 
encapsulate and preserve bioactivity of different biomol-
ecules. [ 27,28 ] Thus, a novel approach is needed to deliver 
both FA and BMP-2 for dentin regeneration. 
 In this work, we synthesized chitosan- graft -poly(lactic 
acid) (CS- g -PLA) copolymers and developed micelle-in-
microsphere assemblies (Figure  1 ), and used them to 
simultaneously co-deliver hydrophobic and hydrophilic 
biomolecules with distinct release profi les. This delivery 
system provides an innovative solution to the need for co-
delivery of biochemically distinct molecules to promote 
dentin regeneration in an infl ammatory environment. 
 2.  Results and Discussion 
 We fi rst prepared CS- g -PLA copolymers with various 
amounts of poly(lactic acid) (PLA) by graft copolymeriza-
tion. As shown in Figure  2 A, we developed a new way to 
accomplish the desired copolymerization. Lactic acid (LA) 
was used to dissolve chitosan (CS) since the latter can 
only be dissolved in a weak acidic environment. Fourier 
transform infrared spectroscopy (FT-IR; Figure  2 B) and  1 H 
nuclear magnetic resonance ( 1 H NMR; Figure  2 C) charac-
terizations were used to verify the success of this method 
of graft copolymerization. The characteristic peaks of high 
molecular weight PLA and their intensities increased 
accordingly when the weight ratios of LA/CS progressed 
from 10:1 to 40:1. The introduction of PLA grafts did not 
compromise the superior thermostability of CS (Figure S1, 
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 Figure 1.  Schematic illustration for the preparation of CS- g -PLA copolymer based micelle-in-microsphere assemblies for the simultaneous 
co-delivery of hydrophobic and hydrophilic biomolecules. Hydrophobic biomolecules (green dots) were bound to hydrophobic cores of CS-
 g -PLA micelle-like nanospheres. Hydrophilic biomolecules (red dots) were bound to hydrophilic shells and interspaces of CS- g -PLA micelle-
like nanospheres.
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Supporting Information), which is benefi cial for its clinical 
applicability as carrier materials. 
 To verify the formation of micelle-like particles of 
three synthesized CS- g -PLA copolymers, their structures 
were examined using transmission electron microscopy 
(TEM) and a particle analyzer. TEM observation showed 
that both CS- g -PLA-2 and CS- g -PLA-3 could form spher-
ical structures with diameters of ≈200 nm (Figure  3 A,C), 
whereas CS- g -PLA-1 failed to form an integrated structure 
(Figure S2, Supporting Information). Particle analysis 
Macromol. Biosci. 2016,  16,  1039−1047
 Figure 2.  Synthesis and characterization of CS- g -PLA copolymers. A) Synthetic strategy of CS- g -PLA copolymers initiated by Sn(Oct) 2 . B) FT-IR 
spectral variations of CS- g -PLA copolymers with increasing LA/CS ratios of 10:1, 20:1, and 40:1, named as CS- g -PLA-1, 2, and 3, respectively. The 
spectra were compared with control CS and high molecular weight PLA. The representative signals of PLA appeared in all three CS- g -PLA 
copolymers, predominantly with ester carbonyl (C = O) stretch at 1749 cm −1 . C)  1 H NMR spectra variations of CS- g -PLA-1, 2, and 3, compared 
with the control CS and high molecular weight PLA. The spectra of all three CS- g -PLA copolymers were recorded in D 2 O, while the spectra of 
CS and PLA were recorded in DCl/D 2 O and CDCl 3 , respectively. The representative signals of PLA appeared in all three CS- g -PLA copolymers, 
predominantly with chemical shifts of methyl (CH 3 ) at 1.59 ppm and methine (CH) at 5.17 ppm. The grafting percentage (GP) of PLA was 
determined by the relative integral intensities of PLA and CS units as follows: GP = ( I 5.17 ppm × MW L-LA )/( I 3.17 ppm × MW CS unit ) × 100%. Here, 
MW L-LA is 90 g mol −1 and MW CS unit is 169.4 g mol −1 when its degree of deacetylation is 80%. The calculated GP in CS- g -PLA-1, 2, and 3 was 
26.0%, 61.1%, and 120.6%, respectively.
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further revealed that the mean diameters of CS- g -PLA-2 
and CS- g -PLA-3 micelles were 196.8 and 261.9 nm 
(Figure  3 B,D), respectively, and the corresponding zeta 
potentials were 35.3 and 30.0 mV (Figure S3, Supporting 
Information). The positive zeta potentials suggest that CS 
mainly constituted the shells while PLA, which is known 
to have a negative zeta potential, is primarily located 
in the cores. With increased LA/CS weight ratios, the 
cores became thicker accordingly and the micelles also 
increased in size. 
 Micelle-like structures have enhanced permeability 
and drug retention. In an ideal system for the delivery of 
biomolecules for tissue regeneration, the encapsulated 
biomolecules are delivered to the cells and the carrier 
material does not enter the cells. [ 11,29,30 ] However, phago-
cytosis of the CS- g -PLA micelle-like nanospheres was 
observed when they were co-cultured with human dental 
pulp stem cells (DPSCs). Upon entering the cells, the nano-
spheres aggregated primarily within cellular lysosomes 
after co-culturing for 1 d (Figure S4, Supporting Infor-
mation). To prevent phagocytosis of the small micelle-
like nanospheres, the core–shell structure was further 
crosslinked into microspheres in the presence of trip-
olyphosphate (TPP). As shown in Figure  4 , both CS- g -PLA-2 
and CS- g -PLA-3 micelles could be assembled into micro-
spheres. CS- g -PLA-1 was omitted from these experiments 
because it did not form a micelle-like structure in an 
aqueous system. At high magnifi cation, nano-sized pro-
tuberances were observed on the microsphere surfaces 
(Figure  4 C,G), which corresponded to the micelle-like 
structure shown in Figure  3 . After being crosslinked, the 
average diameters of CS- g -PLA-2 and CS- g -PLA-3 micro-
spheres were 72.7 and 78.7 μm, respectively (Figure  4 D,H), 
and could not be phagocytized by DPSCs (Figure S4, 
Supporting Information). 
 Traditionally, CS and PLA have been used indepen-
dently as delivery vehicles for a single type of biomol-
ecule. [ 27,31–33 ] To extend their function to co-delivery 
of different types of biomolecules, considerable efforts 
were made to develop CS and PLA-based composites 
often by physical blending. [ 34–37 ] This led to a number 
of CS/PLA hybrids, but the two components tended to 
distribute unevenly within the composite because their 
miscibility is poor, due to the lack of a common solvents. 
Copolymers synthesized using CS with a low molecular 
weight PLA or its precursor as a chemical modifi er are 
heterogeneous and therefore exhibit irreproducible 
properties. [ 38,39 ] As a result, most CS and PLA composites 
Macromol. Biosci. 2016,  16,  1039−1047
 Figure 3.  Characterization of CS- g -PLA copolymeric micelle-like nanospheres. A) TEM micrograph of CS- g -PLA-2 micelle-like nanospheres 
stained with phosphotungstic acid (PTA). B) Size distribution of CS- g -PLA-2 micelle-like nanospheres determined by particle analyzer.
C) TEM micrograph of CS- g -PLA-3 micelle-like nanospheres stained with PTA. D) Size distribution of CS- g -PLA-3 micelle-like nanospheres 
determined by particle analyzer.
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are currently still unsuitable for co-delivery of multiple 
biomolecules. 
 In order to validate the potential of CS- g -PLA micelle-
in-microsphere structure to co-deliver biomolecules 
with distinct physiochemical characteristics, coumarin-6 
(a typical hydrophobic fl uorochrome) and bovine serum 
albumin (BSA; a representative hydrophilic model pro-
tein) were sequentially encapsulated into CS- g -PLA 
Macromol. Biosci. 2016,  16,  1039−1047
 Figure 4.  Morphology and size distributions of CS- g -PLA copolymeric microspheres assembled from micelle-like nanospheres. A–C) SEM 
micrographs of CS- g -PLA-2 microspheres with increasing magnifi cation: A) 250×; B) 1000×; C) 5000×. D) The size distributions of CS- g -PLA-2 
microspheres measure using a laser particle size analyzer. E–G) SEM micrographs of CS- g -PLA-3 microspheres with increasing magnifi cation: 
E) 250×; F) 1000×; G) 5000×. H) The size distributions of CS- g -PLA-3 microspheres measured using a laser particle size analyzer.
 Figure 5.  Distribution and co-delivery of hydrophobic coumarin-6 and hydrophilic BSA (or TRITC-BSA) in CS- g -PLA copolymeric microspheres 
assembled from micelle-like nanospheres. A) Representative LSCM images of fl uorescent coumarin-6 (green fl uorescence) and TRITC-BSA 
(red fl uorescence) to exhibit their distinct distribution in microspheres. B) Release profi les of BSA from CS- g -PLA-2 and CS- g -PLA-3 micro-
spheres in vitro in PBS buffer. A biphasic release pattern was presented over two weeks with a fast release phase in the fi rst week and a 
sustained slow release phase in the second week. C) Release profi les of coumarin-6 from CS- g -PLA-2 and CS- g -PLA-3 microspheres in vitro 
in PBS buffer. A nearly linear release pattern was observed during the fi rst two weeks.
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microspheres and the in vitro release kinetics were 
investigated. Laser scanning confocal microscopy (LSCM) 
revealed that coumarin-6 (green fl uorescence) and tetra-
methylrhodamine isothiocyanate (TRITC)-conjugated 
BSA (TRITC-BSA, red fl uorescence) were observed in dis-
tinct areas of the microspheres (Figure  5 A). Coumarin-6 
appeared mainly within spherical areas and some further 
assembled aggregates, whereas TRITC-BSA was observed 
surrounding the spherical aggregates and formed a retic-
ulate structure. During two weeks in phosphate buffered 
saline (PBS, pH 7.4), BSA displayed a biphasic release pat-
tern characterized by a rapid release phase in the fi rst 
week and a sustained slow release phase in the following 
week (Figure  5 B). In contrast, coumarin-6 maintained 
a more linear release over the two week time period 
(Figure  5 C). When compared with the CS- g -PLA-2 micro-
spheres, the CS- g -PLA-3 microspheres showed decreased 
rates of BSA and coumarin-6 release. 
 Both LSCM and in vitro release results further demon-
strate that coumarin-6 was located within the micellar 
cores while BSA was distributed on the surface of 
micellar shells and the interspaces among micelles. This 
is consistent with the schematic illustration in Figure  1 
depicting the sequential addition of the two molecules 
during micelle and microsphere preparation. As a result, 
each molecule displayed a distinct in vitro release pro-
fi le. Due to the hydrophilicity of CS, BSA released rapidly 
following immersion of microspheres in PBS. Because 
coumarin-6 was primarily entrapped in the cores of CS-
 g -PLA micelles, its release correlated with the degrada-
tion of PLA and the diffusion through PLA. Because of the 
increased molecular weight and the amount of the PLA 
in the CS- g -PLA-3 microspheres, this preparation resulted 
in a slower release rate of coumarin-6. TPP crosslinking 
also had signifi cant impact on the release of coumarin-6. 
In uncrosslinked CS- g -PLA micelle formulations, most 
coumarin-6 was released within one week with slight 
burst release on the fi rst day and a linear release for 
the following 6 d (Figure S5, Supporting Information). 
After assembling micelles into microspheres through 
crosslinking, the burst release was minimized and the 
release could be sustained over two weeks. 
 To further evaluate the utility of the new CS- g -PLA 
micelle-in-microsphere co-delivery system, hydrophobic 
FA and hydrophilic BMP-2 were loaded and delivered 
to treat DPSCs. In the CS- g -PLA-2 micelles, 5.8 mg g −1 
of FA was loaded at a loading effi ciency of 36.2%. For 
BMP-2, 8.0 mg g −1 was loaded at 64.6% loading effi ciency. 
(Table  1 ). As illustrated in Figure  1 , hydrophobic FA mol-
ecules were encapsulated into hydrophobic cores of 
CS- g -PLA copolymeric micelle-like nanospheres. Hydro-
philic BMP-2 molecules were then introduced and the 
micellar emulsion was crosslinked into microspheres 
through electrostatic interaction with TPP. Hydrophilic 
biomolecules were therefore mainly distributed in hydro-
philic interspaces between the crosslinked micelle-like 
nanospheres and on the outer CS layer of micelles. BMP-2 
was released at a faster rate to promote dentinogen-
esis at an early stage of treatment. FA was released in a 
sustained manner to inhibit infl ammation during the 
entirety of the healing process. Paclitaxel and vascular 
endothelial growth factor (VEGF) were co-encapsulated in 
a microparticles/hydrogel composite previously, [ 40 ] where 
VEGF was used to encourage the growth of endothelial 
cells while paclitaxel was used to inhibit the growth of 
smooth muscle cells. The major benefi t of the present co-
delivery system is that different biomolecules can be pre-
sented compartmentally and their release profi les can be 
manipulated individually by varying LA and CS weight 
ratios (LA/CS) to meet the desired parameters for cell 
growth and tissue regeneration. In vitro release profi les 
(Figure  6 A) showed similar patterns to coumarin-6 and 
BSA release (Figure  5 B,C). After two weeks, the cumula-
tive releases of both FA and BMP-2 reached ≈90%. Despite 
a certain degree of deformation and conglutination, most 
microspheres still kept their original spherical shape 
after a two-week immersion in PBS (Figure S6, Supporting 
Information). 
 The effects of FA and BMP-2 released from CS- g -PLA-2 
microspheres were investigated in LPS treated DPSCs. LPS 
is a major component of the outer membrane in gram-
negative bacteria and can elicit infl ammatory cytokine 
expression and apoptosis of DPSCs. In this cell culture 
model, LPS was used to induce an infl ammatory reac-
tion. [ 14 ] Four groups were compared to a negative control: 
LPS alone, LPS and BMP-2, LPS and FA, and a co-delivery 
group of LPS with BMP-2 and FA. A constant linear release 
of FA was intended to persistently relieve the infl amma-
tion reaction. This approach was chosen because a large 
burst of FA levels has been reported to evoke unwanted 
Macromol. Biosci. 2016,  16,  1039−1047
  Table 1.  FA and BMP-2 loading content and loading effi ciency in CS- g -PLA-2 micelles and microspheres, respectively ( n = 3). 
Sample FA dosage 
[mg g −1 ]
FA loading content a) 
[mg g −1 ]
FA loading effi ciency a) 
[%]
BMP-2 dosage 
[mg g −1 ]
BMP-2 loading 
content b) 
[mg g −1 ]
BMP-2 loading 
effi ciency b) [%]
CS- g -PLA-2 10.0 5.8 ± 1.3 36.2 ± 6.5 10.0 8.0 ± 1.4 64.6 ± 8.1
 a)Data from the CS- g -PLA-2 micelle sample;  b) Data from the CS- g -PLA-2 microsphere sample. 
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Macromol. Biosci. 2016,  16,  1039−1047
side effects. [ 41 ] Rapid BMP-2 release during the initial 
phase was designed to recruit DPSCs to the injury site 
and the subsequent sustained release of BMP-2 facili-
tated the differentiation of DPSCs into functional cells. 
Alkaline phosphatase (ALP), runt-related transcription 
factor 2 (RUNX2), and osteocalcin (OCN) are major bio-
markers in hard tissue regeneration. Dentin sialophos-
phoprotein (DSPP), which is regarded as a dentin specifi c 
protein, is a major noncollagenous dentin matrix protein 
during dentin formation and is present at a high concen-
tration in mature dentin. [ 42 ] Therefore, ALP activity and 
gene expression of RUNX2, OCN, and DSPP were meas-
ured on day 7 of treatment. ALP activity was signifi cantly 
decreased in DPSCs treated with LPS alone. Treatment 
with LPS and FA up-regulated ALP activity above nega-
tive control levels, suggesting FA successfully inhibited 
infl ammation. Delivery of LPS and BMP-2 resulted in 
some recovery of ALP activity, but still below the levels of 
the negative control, whereas co-delivery of FA and BMP-2 
synergistically enhanced the ALP activity when com-
pared to single delivery groups (Figure  6 C). Consistently, 
RUNX2, OCN, and DSPP expression were down-regulated 
in LPS-treated DPSCs. Addition of FA recovered RUNX2, 
OCN, and DSPP gene expression while BMP-2 alone had 
no effect. Co-delivery of FA and BMP-2 promoted the gene 
expression above negative control when compared with 
the single delivery groups (Figure  6 D). To further investi-
gate the effects of the co-delivery system for an extended 
period of time, calcium was then extracted and quantifi ed 
on day 21 of treatment. Consistent with the ALP activity 
and the expression of odontogenic genes, the calcium con-
tent increased signifi cantly with the co-delivery group, 
demonstrating the synergistic effect of FA and BMP-2 
co-delivery (Figure  6 B). In summary, CS-g-PLA-2 micro-
spheres, by co-delivery of FA and BMP-2, can suppress 
infl ammation effect and enhance dentin regeneration. 
 3.  Conclusions 
 CS- g -PLA copolymeric microspheres assembled from 
micelle-like core–shell nanospheres have been devel-
oped as co-delivery vehicles of multiple biomolecules. 
This co-delivery system contains hydrophobic micellar 
cores and hydrophilic shells along with intermicellar 
spaces and has been demonstrated to effectively deliver 
 Figure 6.  Synergistic effects of co-delivered FA and BMP-2 on mineralization of DPSCs under LPS treatment. A) Release profi les of FA and 
BMP-2 from CS- g -PLA-2 microspheres over two weeks in PBS buffer. B) ALP staining and activities of LPS-treated DPSCs after 7 d of incubation 
with CS- g -PLA-2 microspheres. C) RUNX2 and OCN gene expression profi les of LPS-treated DPSCs after 7 d of incubation with CS- g -PLA-2 
microspheres. D) Calcium content quantifi cation of LPS-treated DPSCs after 21 d of incubation with CS- g -PLA-2 microspheres.
X. Niu et al.
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water-insoluble anti-infl ammatory drug FA and water-sol-
uble osteo/odontogenic growth factor BMP-2, with distinct 
and tunable release patterns. This micelle-in-microsphere 
co-delivery platform has potential for dentin regenera-
tion and other biomolecule-mediated tissue regeneration 
applications. This platform is particularly suitable for the 
concurrent delivery of synergistic hydrophobic and hydro-
philic biomolecules. 
 4.  Experimental Section 
 Preparation and Characterization of CS-g-PLA Copolymers : CS, 
L-lactic acid (L-LA), and Sn(Oct) 2 were purchased from Sigma-
Aldrich (St. Louis, MO, USA) and CS has an dynamic viscosity 
of 200–800 cP and degree of deacetylation 75%–85%. L-LA and 
CS with weight ratios of 10:1, 20:1, and 40:1 were co-dispersed 
in distilled water, respectively. The obtained transparent 
solutions were lyophilized to form CS lactate paste. Sn(Oct) 2 
(in tetrahydrofuran) with a molar ratio of 0.05% to the L-LA 
was added. Under rigorous mechanical stirring, the graft 
copolymerization was carried out at 100 °C in vacuum for 5 h. 
The crude products were then extracted with excess amounts 
of toluene and further lyophilized. The obtained copolymers 
were named CS- g -PLA-1, CS- g -PLA-2, and CS- g -PLA-3 accordingly, 
and characterized by FT-IR (Perkin Elmer 1800),  1 H NMR (Varian 
MR400), differential scanning calorimetry (DSC, Perkin Elmer 
DSC-7), and thermogravimetric analysis (TGA, Perkin Elmer 
TGA-7). 
 Preparation and Characterization of CS-g-PLA Micelles : The 
micelles were prepared by dialysis method. The CS- g -PLA 
copolymers were dissolved in dimethyl sulfoxide (DMSO). 
The resulting solution was transferred to dialysis tubing 
(MWCO 6–8 kDa) and dialyzed against deionized water for 24 h. 
The medium was renewed every 6 h. The dialyzed solution was 
collected and characterized by TEM (JEOL JEM-2100F) and Particle 
Analyzer (Beckman Coulter Delsa Nano C). For TEM observation, the 
samples were dropped onto a carbon coated copper grid (200 mesh) 
and stained using PTA (1%, v:v). The hydrophobic fl uorochrome 
coumarin-6 or anti-infl ammatory drug FA loaded micelles were 
prepared using the same method and these biomolecules were 
co-dissolved in DMSO with CS- g -PLA copolymers. 
 Aggregation of Micelles : The dialyzed solution was 
concentrated to 3% (w:v) and used to fabricate microspheres by 
emulsion-ionic crosslinking technique. Typically, 10 mL micellar 
solution was dropped into 100 mL of mineral oil containing 
2% (w:v) surfactant span-80 and agitated mechanically for 
2 h at room temperature to form a water-in-oil (W/O) emulsion. 
Then, 12.5 mL 5% (w:v) TPP solution was added dropwise to the 
emulsion and stirred for another 2 h to stabilize the microspheres 
through electrostatic interaction between CS- g -PLA micelles 
and TPP. The resulting microsphere suspension was repeatedly 
washed with excess amounts of petroleum ether and 2-propanol, 
and then lyophilized. The morphology of microspheres was 
observed under scanning electron microscope (SEM; Philips XL30 
FEG). The mean size and size distribution of microspheres were 
evaluated by laser particle size analyzer (Mastersizer 2000). The 
dried microspheres were suspended in deionized water and 
sonicated for 1 min before measurement. The measuring ranges 
were 0.020–2000 μm. The microspheres loaded with hydrophilic 
BSA or BMP-2 were prepared using the same method and these 
biomolecules were dissolved in CS- g -PLA micellar solution. BSA 
was replaced by TRITC-BSA for LSCM characterization (Nikon 
TS-100). 
 In Vitro Release : The micellar aggregates encapsulated 
with various hydrophobic and hydrophilic biomolecules were 
immersed in 0.01  M sterile PBS (pH 7.4) and kept at 37 °C on an 
orbital shaker. At predetermined time intervals, the supernatant 
was collected and equivalent volume of fresh PBS was added 
to each sample. The coumarin-6 concentration in the release 
medium was determined using a Varioskan Flash multimode 
reader (Thermo Scientifi c) with excitation 450 nm and emission 
505 nm. The FA concentration was determined using a UV 
spectrometer with detection wavelength of 237 nm. The BSA 
concentration was determined using Micro BCA protein assay 
kit (Thermo scientifi c, Rockford, IL, USA) according to the 
manufacturer’s instructions. The BMP-2 concentration was 
analyzed using a commercially available human BMP-2 enzyme-
linked immunosorbent assay (ELISA) kit (PeproTech, Rocky Hill, 
NJ, USA) following the manufacturer’s protocol. 
 Cell Culture and Seeding : Human DPSCs were obtained from 
the Center of Craniofacial Molecular Biology, School of Dentistry, 
University of Southern California, which were isolated according 
to the protocol reported previously. [ 43 ] The DPSCs were cultured 
with alpha modifi cation of Eagle’s minimum essential medium 
(α-MEM, Invitrogen, Carlsbad, CA) supplemented with 10% fetal 
bovine serum (FBS, Gibico, USA) and penicillin-streptomycin 
(100 U mL −1 and 100 μg mL −1 , Gibico, USA), and incubated at 
37 °C in 5% CO 2 . The culture medium was changed every two 
days. DPSCs of passages 4–6 were used in the following studies. 
 ALP Assay : ALP activity was examined using SensoLyte 
pNPP Alkaline Phosphatase Assay Kit (AnaSpec, Fremont, CA) 
according to the manufacturer’s procedures. Briefl y, DPSCs at a 
density of 2 × 10 4 cells per well were seeded in 24-well plates. On 
the following day, cells were cultured in odontogenic medium, 
which contained α-MEM supplemented with 10% FBS, 50 μg mL −1 
ascorbic acid, and 5 × 10 −3  M β-glycerophosphate. They were then 
incubated on an orbital shaker at 37 °C in 5% CO 2 . CS- g -PLA 
microspheres (0.5 mg mL −1 ) were added in odontogenic medium 
with 2.0 μg mL −1 LPS. Half of the medium was changed every two 
days. After DPSCs were cultured for 7 d, the cells were rinsed with 
PBS and washing buffer, homogenized in a 250 μL lysis buffer on 
ice for 10 min. The samples with lysis buffer were centrifuged 
at 2500 g at 4 °C for 10 min and 50 μL supernatant was used for 
ALP activity quantifi cation assay. The absorbance was measured 
at 405 nm with Varioskan Flash multimode reader. The ALP 
activity of cells was normalized with total protein content that 
was quantifi ed by Micro BCA protein assay kit. Meanwhile, ALP 
staining was further examined by using Leukocyte Alkaline 
Phosphatase Kit (Sigma-Aldrich, St. Louis, MO, USA) according to 
the manufacturer’s protocols. 
 Quantitative Real Time Polymerase Chain Reaction : The 
DPSCs were cultured with CS- g -PLA microspheres for 7 d and 
they were treated consistently with the above ALP assay. Total 
RNA was extracted from DPSCs by using RNA Mini kit (Qiagen, 
Valencia, CA) and 2 μg total RNA was converted to cDNA with 
reverse transcription reagents (Taqman, Applied Biosystems, 
Microspheres Assembled from Chitosan-Graft-Poly(lactic acid) Micelle-Like Core–Shell Nanospheres . . .
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Foster City, CA). Real time polymerase chain reaction (PCR) was 
carried out in a total volume of 30 μL in Taqman Universal 
PCR Master Mix (Applied Biosystems) with 2 μL cDNA and 
1.5 μL predesigned primers and probes (Applied Biosystems) 
for RUNX2 (Hs00231692_m1), OCN (Hs01587813_g1), and DSPP 
(Hs00171962_ml). The reactions were performed using ABI 
Prism 7500 Real time PCR System (Applied Biosystems). The 
gene expression was normalized against housekeeping gene 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression. 
 Calcium Content Quantifi cation : After 21 d of culture, CS- g -PLA 
microspheres treated DPSCs were rinsed two times with PBS, 
and 200 μL of 0.5  N hydrochloric acid was added to each well. 
The lyses were incubated overnight on an orbital shaker and col-
lected in tubes. The total calcium content was tested following 
instruction provided by the Stanbio Laboratory calcium liqui-
color kit (Boerne, TX, USA). 
 Statistical Analysis : Data were expressed as mean ± standard 
deviation (SD). One-way analysis of variance (ANOVA) was used 
to test the between-group differences. Statistical signifi cance 
was determined as  P < 0.05. 
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 Supporting Information is available from the Wiley Online 
Library or from the author. 
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